This menu provides the list of EV miRNAs identified by high-throughput analyses.
Refresh all contents
Search:
Dataset accession
miRBase accession
Mature name
Orthologous group
Superdomain:
All
Prokaryote
Eukaryote
Filter datasets:
- "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
- "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
By species
Homo sapiens
In vitro/In vivo
Ex vivo
In vitro
In vivo
By sample type
Bone marrow stromal cells
Breast cancer cell (MCF7)
Leukemia cell (K562)
Liver cancer cells (CSQT-2)
Multiple myeloma cells (U266)
Serum
By sample status
Extremely severe hand, foot, and mouth disease
Hypoxic condition (24 hr)
Multiple myeloma patients
Normal
Normal_old
Survived under long-term hypoxia
Maximum false positive rate (FPR):
Maximum true positive rate (TPR):
- FPR is the probability that an absent miRNA accidently have higher intensity than that miRNA.
- TPR is the percentile of miRNA among the present miRNAs.
Please see user manual in the contact us/help menu for detail.
Number of molecules in one page:
100
200
All
The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.
Since there are multiple primers in the microarray, the same miRNA can have several FPR and TPR values.
Mature name
miRBase accession
FPR
TPR
Publication
Orthologous group
Identification count
All / Prokaryote / Eukaryote
(FPR<0.05,TPR<0.5)
hsa-miR-429
MIMAT0001536
0.0e+0
4.9e-1
Selective release of microRNA species from normal and malignant mammary epithelial cells.
PLoS One. 2010 Oct 20;5(10):e13515.
MIPF0000019_1
41
/
0
/
41
hsa-miR-429
MIMAT0001536
0.0e+0
5.0e-1
Selective release of microRNA species from normal and malignant mammary epithelial cells.
PLoS One. 2010 Oct 20;5(10):e13515.
MIPF0000019_1
41
/
0
/
41
hsa-miR-429
MIMAT0001536
1.3e-7
0.0e+0
Exosomes derived from hypoxic leukemia cells enhance tube formation in endothelial cells.
J Biol Chem. 2013 Nov 29;288(48):34343-51. doi: 10.1074/jbc.M113.480822. Epub 2013 Oct 16.
MIPF0000019_1
41
/
0
/
41
hsa-miR-429
MIMAT0001536
0.0e+0
4.7e-1
MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease.
BMC Infect Dis. 2014 Sep 17;14(1):506. doi: 10.1186/1471-2334-14-506.
MIPF0000019_1
41
/
0
/
41
hsa-miR-429
MIMAT0001536
9.3e-4
9.3e-4
Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1.
Blood. 2014 Oct 15. pii: blood-2014-05-576116.
MIPF0000019_1
41
/
0
/
41
hsa-miR-429
MIMAT0001536
1.1e-3
1.1e-3
Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1.
Blood. 2014 Oct 15. pii: blood-2014-05-576116.
MIPF0000019_1
41
/
0
/
41
hsa-miR-429
MIMAT0001536
6.6e-9
0.0e+0
Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1.
Blood. 2014 Oct 15. pii: blood-2014-05-576116.
MIPF0000019_1
41
/
0
/
41
hsa-miR-429
MIMAT0001536
4.6e-5
0.0e+0
Replenishing exosomes from older bone marrow stromal cells with miR-340 inhibits myeloma-related angiogenesis.
Blood Adv. 2017 May 16;1(13):812-823. doi: 10.1182/bloodadvances.2016003251. eCollection 2017 May 23.
MIPF0000019_1
41
/
0
/
41
hsa-miR-429
MIMAT0001536
1.8e-2
1.8e-2
Replenishing exosomes from older bone marrow stromal cells with miR-340 inhibits myeloma-related angiogenesis.
Blood Adv. 2017 May 16;1(13):812-823. doi: 10.1182/bloodadvances.2016003251. eCollection 2017 May 23.
MIPF0000019_1
41
/
0
/
41
hsa-miR-429
MIMAT0001536
0.0e+0
2.2e-1
Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.
MIPF0000019_1
41
/
0
/
41
[1]